1
|
Eremina OE, Yarenkov NR, Bikbaeva GI, Kapitanova OO, Samodelova MV, Shekhovtsova TN, Kolesnikov IE, Syuy AV, Arsenin AV, Volkov VS, Tselikov GI, Novikov SM, Manshina AA, Veselova IA. Silver nanoparticle-based SERS sensors for sensitive detection of amyloid-β aggregates in biological fluids. Talanta 2024; 266:124970. [PMID: 37536108 DOI: 10.1016/j.talanta.2023.124970] [Citation(s) in RCA: 4] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/26/2023] [Revised: 07/11/2023] [Accepted: 07/18/2023] [Indexed: 08/05/2023]
Abstract
One of the hallmarks of Alzheimer's disease (AD) pathogenesis is the production, aggregation, and deposition of amyloid-β (Aβ) peptide. Surface-enhanced Raman spectroscopy (SERS) is a promising analytical technique capable of providing valuable information on chemical composition and molecule conformations in biological samples. However, one of the main challenges for introducing the SERS technique into the practice is preparation of scalable and at the same time stable nanostructured sensors with uniform spatial distribution of nanoparticles. Herein, we propose SERS platforms for reproducible, sensitive, label-free quantification of amyloid-β aggregates for short-wavelength - 532 and 633 nm - lasers. A SERS sensor - based on silver nanoparticles immobilized into a chitosan film (AgNP/CS) - provided a uniform distribution of AgNPs from a colloidal suspension across the SERS sensor, resulting in nanomolar limits of detection (LODs) for Aβ42 aggregates with a portable 532 nm laser. The laser-induced deposition was used to obtain denser periodic plasmonic sensors (AgNP/LID) with a uniform nanoparticle distribution. The AgNP/LID SERS sensor allowed for 15 pM LOD for Aβ42 aggregates with 633 nm laser. Notably, both nanostructured substrates allowed to distinguish amyloid aggregates from monomers. Therefore, our approach demonstrated applicability of SERS for detection of macromolecular volumetric objects as amyloid-β aggregates for fundamental biological studies as well as for "point-of-care" diagnostics and screening for early stages of neurodegenerative diseases.
Collapse
Affiliation(s)
- Olga E Eremina
- Chemistry Department, Lomonosov Moscow State University, Moscow, Russia.
| | - Nikita R Yarenkov
- Chemistry Department, Lomonosov Moscow State University, Moscow, Russia
| | - Gulia I Bikbaeva
- Institute of Chemistry, Saint-Petersburg State University, Saint-Petersburg, Russia
| | - Olesya O Kapitanova
- Chemistry Department, Lomonosov Moscow State University, Moscow, Russia; Center for Photonics and 2D Materials, Moscow Institute of Physics and Technology, Dolgoprudny, Russia
| | | | | | - Ilya E Kolesnikov
- Center for Optical and Laser Materials Research, Research Park, Saint-Petersburg State University, Saint-Petersburg, Russia
| | - Alexander V Syuy
- Center for Photonics and 2D Materials, Moscow Institute of Physics and Technology, Dolgoprudny, Russia; Institute of High Technologies and Advanced Materials of the Far Eastern Federal University, Vladivostok, Russia
| | - Aleksey V Arsenin
- Center for Photonics and 2D Materials, Moscow Institute of Physics and Technology, Dolgoprudny, Russia; Emerging Technologies Research Center, XPANCEO, Dubai, United Arab Emirates
| | - Valentyn S Volkov
- Center for Photonics and 2D Materials, Moscow Institute of Physics and Technology, Dolgoprudny, Russia; Laboratory of Advanced Functional Materials, Yerevan State University, Yerevan, Armenia
| | - Gleb I Tselikov
- Center for Photonics and 2D Materials, Moscow Institute of Physics and Technology, Dolgoprudny, Russia
| | - Sergey M Novikov
- Center for Photonics and 2D Materials, Moscow Institute of Physics and Technology, Dolgoprudny, Russia
| | - Alina A Manshina
- Institute of Chemistry, Saint-Petersburg State University, Saint-Petersburg, Russia
| | - Irina A Veselova
- Chemistry Department, Lomonosov Moscow State University, Moscow, Russia
| |
Collapse
|
2
|
Cui Y, Zhao J, Li H. Chromogenic Mechanisms of Colorimetric Sensors Based on Gold Nanoparticles. BIOSENSORS 2023; 13:801. [PMID: 37622887 PMCID: PMC10452725 DOI: 10.3390/bios13080801] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/03/2023] [Revised: 07/31/2023] [Accepted: 08/08/2023] [Indexed: 08/26/2023]
Abstract
The colorimetric signal readout method is widely used in visualized analyses for its advantages, including visualization of test results, simple and fast operations, low detection cost and fast response time. Gold nanoparticles (Au NPs), which not only exhibit enzyme-like activity but also have the advantages of tunable localized surface plasmon resonance (LSPR), high stability, good biocompatibility and easily modified properties, provide excellent platforms for the construction of colorimetric sensors. They are widely used in environmental monitoring, biomedicine, the food industry and other fields. This review focuses on the chromogenic mechanisms of colorimetric sensors based on Au NPs adopting two different sensing strategies and summarizes significant advances in Au NP-based colorimetric sensing with enzyme-like activity and tunable LSPR characteristics. In addition, the sensing strategies based on the LSPR properties of Au NPs are classified into four modulation methods: aggregation, surface modification, deposition and etching, and the current status of visual detection of various analytes is discussed. Finally, the review further discusses the limitations of current Au NP-based detection strategies and the promising prospects of Au NPs as colorimetric sensors, guiding the design of novel colorimetric sensors.
Collapse
Affiliation(s)
- Yanyun Cui
- College of Chemistry and Materials Engineering, Beijing Technology and Business University, Beijing 100048, China; (J.Z.); (H.L.)
| | | | | |
Collapse
|
3
|
Kumar S, Shukla MK, Sharma AK, Jayaprakash GK, Tonk RK, Chellappan DK, Singh SK, Dua K, Ahmed F, Bhattacharyya S, Kumar D. Metal-based nanomaterials and nanocomposites as promising frontier in cancer chemotherapy. MedComm (Beijing) 2023; 4:e253. [PMID: 37025253 PMCID: PMC10072971 DOI: 10.1002/mco2.253] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/06/2022] [Revised: 03/05/2023] [Accepted: 03/09/2023] [Indexed: 04/07/2023] Open
Abstract
Cancer is a disease associated with complex pathology and one of the most prevalent and leading reasons for mortality in the world. Current chemotherapy has challenges with cytotoxicity, selectivity, multidrug resistance, and the formation of stemlike cells. Nanomaterials (NMs) have unique properties that make them useful for various diagnostic and therapeutic purposes in cancer research. NMs can be engineered to target cancer cells for early detection and can deliver drugs directly to cancer cells, reducing side effects and improving treatment efficacy. Several of NMs can also be used for photothermal therapy to destroy cancer cells or enhance immune response to cancer by delivering immune-stimulating molecules to immune cells or modulating the tumor microenvironment. NMs are being modified to overcome issues, such as toxicity, lack of selectivity, increase drug capacity, and bioavailability, for a wide spectrum of cancer therapies. To improve targeted drug delivery using nano-carriers, noteworthy research is required. Several metal-based NMs have been studied with the expectation of finding a cure for cancer treatment. In this review, the current development and the potential of plant and metal-based NMs with their effects on size and shape have been discussed along with their more effective usage in cancer diagnosis and treatment.
Collapse
Affiliation(s)
- Sunil Kumar
- Department of Pharmaceutical ChemistrySchool of Pharmaceutical SciencesShoolini UniversitySolanHimachal PradeshIndia
| | - Monu Kumar Shukla
- Department of Pharmaceutical ChemistrySchool of Pharmaceutical SciencesShoolini UniversitySolanHimachal PradeshIndia
| | | | | | - Rajiv K. Tonk
- School of Pharmaceutical SciencesDelhi Pharmaceutical Sciences and Research UniversityNew DelhiDelhiIndia
| | | | - Sachin Kumar Singh
- School of Pharmaceutical SciencesLovely Professional UniversityPhagwaraPunjabIndia
| | - Kamal Dua
- Discipline of Pharmacy, Graduate School of HealthUniversity of Technology SydneyUltimoNew South WalesAustralia
- Discipline of Pharmacy, Graduate School of Health, University of Technology SydneySydneyAustralia
- Faculty of Health, Australian Research Centre in Complementary and Integrative MedicineUniversity of Technology SydneySydneyAustralia
| | - Faheem Ahmed
- Department of PhysicsCollege of ScienceKing Faisal UniversityAl‐HofufAl‐AhsaSaudi Arabia
| | | | - Deepak Kumar
- Department of Pharmaceutical ChemistrySchool of Pharmaceutical SciencesShoolini UniversitySolanHimachal PradeshIndia
| |
Collapse
|
4
|
Chauhan P, Bhargava A, Kumari R, Ratre P, Tiwari R, Kumar Srivastava R, Yu Goryacheva I, Kumar Mishra P. Surface-enhanced Raman scattering biosensors for detection of oncomiRs in breast cancer. Drug Discov Today 2022; 27:2121-2136. [PMID: 35460892 DOI: 10.1016/j.drudis.2022.04.016] [Citation(s) in RCA: 9] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/13/2022] [Revised: 03/03/2022] [Accepted: 04/13/2022] [Indexed: 12/16/2022]
Abstract
Surface-enhanced Raman scattering (SERS) has emerged as one of the most promising platforms for various biosensing applications. These sensing systems encompass the advantages of specificity, ultra-high sensitivity, stability, low cost, repeatability, and easy-to-use methods. Moreover, their ability to offer a molecular fingerprint and identify the target analyte at low levels make SERS a promising technique for detecting circulating cancer biomarkers with greater sensitivity and reliability. Among the various circulating biomolecules, oncomiRs are emerging as prominent biomarkers for the early screening of breast cancers (BCs). In this review, we provide a comprehensive understanding of different SERS-based biosensors and their application to identify BC-specific oncomiRs. We also discuss different SERS-based sensing strategies, nano-analytical frameworks, and challenges to be addressed for effective clinical translation.
Collapse
Affiliation(s)
- Prachi Chauhan
- Department of Molecular Biology, ICMR-National Institute for Research in Environmental Health, Bhopal, India
| | - Arpit Bhargava
- Department of Molecular Biology, ICMR-National Institute for Research in Environmental Health, Bhopal, India
| | - Roshani Kumari
- Department of Molecular Biology, ICMR-National Institute for Research in Environmental Health, Bhopal, India
| | - Pooja Ratre
- Department of Molecular Biology, ICMR-National Institute for Research in Environmental Health, Bhopal, India
| | - Rajnarayan Tiwari
- Department of Molecular Biology, ICMR-National Institute for Research in Environmental Health, Bhopal, India
| | | | - Irina Yu Goryacheva
- Department of General and Inorganic Chemistry, Saratov State University, Saratov, Russia
| | - Pradyumna Kumar Mishra
- Department of Molecular Biology, ICMR-National Institute for Research in Environmental Health, Bhopal, India.
| |
Collapse
|